# Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam
Canonical URL: https://biopharmsignal.com/news/ENSC/ensysce-biosciences-ceo-presents-at-inaugural-clinical-pain-symposium-in-amsterdam
Ticker: ENSC
Company: Ensysce Biosciences
Source: Ensysce Biosciences
Published: 2026-05-08 12:00 EST
Original Source URL: https://ir.ensysce.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-14 12:00 EST — [Ensysce Biosciences Awarded $5.3 Million Installment in NIDA Funding Completing Multi-Year $15 Million Federal Grant](https://biopharmsignal.com/news/ENSC/ensysce-biosciences-awarded-5-3-million-installment-in-nida-funding-completing-m-ee1ecc0e) — Source: Ensysce Biosciences
- 2026-06-26 12:00 EST — [Ensysce Biosciences Enrolls First Patient in Final Phase of PF614-MPAR-102 Clinical Study](https://biopharmsignal.com/news/ENSC/ensysce-biosciences-enrolls-first-patient-in-final-phase-of-pf614-mpar-102-clini-3e521199) — Source: Ensysce Biosciences
- 2026-05-15 20:15 EST — [Ensysce Biosciences Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/ENSC/ensysce-biosciences-reports-first-quarter-2026-financial-results) — Source: Ensysce Biosciences
- 2026-05-12 12:00 EST — [Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology](https://biopharmsignal.com/news/ENSC/ensysce-biosciences-announces-expansion-of-patent-protection-for-groundbreaking-mpar-r-overdose-protection-technology) — Source: Ensysce Biosciences
- 2026-05-08 12:00 EST — [Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam](https://biopharmsignal.com/news/ENSC/ensysce-biosciences-ceo-presents-at-inaugural-clinical-pain-symposium-in-amsterdam) — Source: Ensysce Biosciences
## Related News
- 2026-07-22 20:15 EST — BFRG — [BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-the-btig-virtual-biotechnology-conference-5880a10e)
- 2026-07-22 20:05 EST — AZTA — [Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-third-quarter-conference-call-and-webcast-48419fff)
- 2026-07-22 20:05 EST — VKTX — [Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026](https://biopharmsignal.com/news/VKTX/viking-therapeutics-to-report-financial-results-for-second-quarter-2026-on-july--bbf2553f)
- 2026-07-22 20:01 EST — AXON — [Axon to Release Second Quarter 2026 Earnings on August 5, 2026](https://biopharmsignal.com/news/AXON/axon-to-release-second-quarter-2026-earnings-on-august-5-2026-66120902)
- 2026-07-22 12:39 EST — ARTL — [New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition](https://biopharmsignal.com/news/ARTL/new-analysis-of-over-50-studies-showed-that-all-the-non-prescription-cbd-product-a3445432)